AstraZeneca Earnings Sentiment
Overview · Sentiment index · updated daily
About the AstraZeneca Earnings Sentiment
Machine-learning signal measuring AstraZeneca earnings sentiment - tracking oncology pipeline momentum, regulatory approval commentary, and pharma sector growth expectations in emerging markets.
Equity sentiment readings are most actionable at the extremes and around earnings cycles. Awareness surges that are not matched by Sentiment moves often precede sharp directional breaks. Single-stock indicators are best read in conjunction with the broader S&P 500 Sentiment to isolate idiosyncratic versus macro-driven moves.
Key drivers
- Earnings estimates and revision trends
- VIX and options skew
- Sector rotation and fund flow data
- Macro data beats / misses relative to consensus
- Short interest and positioning reports
Reading the Sentiment scale
- 0-20Now · 18Extreme BearishOverwhelmingly bearish; often a washed-out, contrarian zone.
- 21-40BearishCoverage leans toward falling prices.
- 41-60NeutralNo directional consensus.
- 61-80BullishCoverage leans toward rising prices.
- 81-100Extreme BullishCrowded bullish consensus; vulnerable to a reversal.
How to use this index
- Use the Sentiment score to gauge the prevailing narrative bias for AstraZeneca at a glance.
- The Awareness score flags unusual spikes in coverage - early-warning signals that often precede price moves.
- Extreme readings (0-20 or 81-100) historically mark periods of heightened volatility and potential reversals.
- Compare across related topics to find cross-asset divergences and correlation breakdowns.
- Pro subscribers can view 3 years of history to calibrate thresholds against past market regimes.
This index is frequently referenced alongside astrazeneca earnings sentiment, pharma outlook, ai biotech sentiment, internet earnings discussion, alternative data equities - helping traders and analysts track AstraZeneca sentiment shifts in real time.
Latest news
AstraZeneca in the news
The headlines feeding this index, newest first.
AstraZeneca China-Made Lung Cancer Drug Heads to U.S.
AstraZeneca is moving to make its China-made lung cancer drug available in the U.S. after long delays that had forced some patients to travel abroad for treatment and raised questions about access to one of the company’s key oncology medicines.
Read moreAstraZeneca Seeks Zoladex Reimbursement Removal in France
AstraZeneca has asked French authorities to remove its breast-cancer treatment Zoladex from reimbursement, a move that will shift costs onto patients and underscores how drug pricing pressure is forcing big pharmaceutical groups to protect margins.
Read moreAstraZeneca Wins FDA Approval for Ultomiris in IgA
AstraZeneca said the U.S. Food and Drug Administration has granted accelerated approval for Ultomiris in adults with immunoglobulin A nephropathy, a rare kidney disease that can progress to renal failure, giving the drugmaker a new near-term growth driver in a high-unmet-need market.
Read moreOracle and AstraZeneca deepen AI healthcare partnership
Oracle and AstraZeneca are deepening their collaboration to connect artificial intelligence research with patient care, a move that underscores how drugmakers are increasingly tying AI spend to clinical and commercial payoff rather than treating it as an isolated tech experiment.
Read moreAmgen, AstraZeneca Tezspire EoE phase 3 results
Amgen and AstraZeneca said Tezspire posted strong phase 3 results in eosinophilic esophagitis, a readout that could open a new multibillion-dollar market for the asthma drug and extend one of the pair’s most important immunology franchises.
Read moreAstraZeneca Partners With Oracle on AI Trial Recruitment
AstraZeneca is moving to use Oracle’s artificial intelligence and healthcare data tools to find patients faster for clinical trials, a partnership that could trim one of the drug industry’s most expensive bottlenecks and support the company’s push toward $80 billion in annual revenue by 2030.
Read moreAstraZeneca to present ESMO cancer trial data
AstraZeneca is set to use next year’s European Society for Medical Oncology meeting to push deeper into combination cancer therapy, with overall-survival data from four Phase III studies and more than 100 abstracts designed to support its broader oncology portfolio.
Read moreAstraZeneca partners with Insitro on AI drug discovery
AstraZeneca is moving deeper into artificial intelligence at the riskiest point in drug development, striking a deal with Insitro that could be worth as much as $1.46 billion to use “virtual humans” to identify the biological targets most likely to produce new medicines for liver and heart disease.
Read moreAstraZeneca Announces $1B Massachusetts Research Site
AstraZeneca is deepening its push into AI-driven drug discovery and automated lab work with a new $1 billion research and laboratory complex in Massachusetts and a separate collaboration worth up to $1.5 billion with AI biotech startup Insitro, underscoring how the industry is racing to replace slower, trial-and-error chemistry with machine-guided discovery.
Read moreAstraZeneca Opens Cambridge Research Center
AstraZeneca has opened a new 570,000-square-foot research center in Cambridge, Massachusetts, in a move that deepens its bet on U.S.-led drug discovery and adds fresh firepower to a $50 billion American investment plan.
Read moreEmbed
Put this indicator on your site
Add the live gauge to your page, or share it with your audience.
Methodology
How the index is built
Data sources, scoring and update cadence, in plain terms.
What is the AstraZeneca index?
Machine-learning signal measuring AstraZeneca earnings sentiment - tracking oncology pipeline momentum, regulatory approval commentary, and pharma sector growth expectations in emerging markets.
How is the AstraZeneca index calculated?
The AstraZeneca index is derived from AI-powered NLP analysis of thousands of online news sources, blogs, and financial commentary. Sentiment scores range from 0 (Extreme Bearish) to 100 (Extreme Bullish), where 50 represents neutral conditions. Awareness scores capture the volume and breadth of coverage for this topic across the media landscape.
How often is the AstraZeneca index updated?
The underlying data pipeline runs once per day. However, the gauge and score displayed on this page reflect a processed snapshot that may be 3–24 hours behind real-time, depending on the topic's update cadence and how quickly new data clears the processing pipeline. The exact timestamp of the data shown is visible in the gauge footer - hover the info icon to see it in your local time.
Why does the gauge show data from a few hours ago?
The gauge reflects a processed data snapshot, not a live feed. Depending on the topic, displayed values can be 3–24 hours behind real-time - fast-moving topics (crypto, equities) update more frequently, while slower-cycle topics (macro, real estate, geopolitics) may have a longer lag. The precise data timestamp is always visible in the gauge footer: hover the info icon to see it in your local time.
Why use sentiment analysis?
Sentiment uses natural language processing to analyze and quantify investors' opinions, which is different from traditional indicators like volatility (VIX), volume, or price trends. This gives you an edge over others who rely solely on price-based data.
How to interpret the figures?
The gauges show the latest indicator percentiles for the last two quarters. Values above 50 mean an upward trend, while below 50 means a downward trend. A reading above 70% signals greed, and below 30% signals fear. When price and sentiment trends diverge, it's a strong sign the trend will continue.
What does awareness represent?
Besides sentiment, we also provide a measurement of awareness - an indicator of media activity expressed as a ratio of topic-dedicated data compared to the total. Values over 50 indicate an increasing media trend and growing investors' interest; less than 50 signals decreasing attention.
What is sentiment analysis and why measure it?
Sentiment analysis is a way to determine whether a piece of text is positive, negative, or neutral. It helps understand how people feel about a topic or product, which is very important for investment, revenue management, and gauging public opinion. It adds important data points to the decision process and is valuable input for many statistical and AI models.
What are some of the key data characteristics?
Raw signals are gathered from proprietary sources covering over 50,000 outlets and ingested every 15 minutes. Processed gauge readings are derived from these signals but are displayed with a delay of 3–24 hours depending on the topic - the exact data timestamp is always shown in the gauge footer. The platform includes 5 years of history, supports 72 languages, and processes over 1 million unique entries daily. Adalytica maintains over 99.5% uptime across all products and data services.
Who benefits the most from the sentiment data?
The products are widely used across various industries, including finance, real estate, cryptocurrency, commodities, and government. They provide tailored insights for tasks like tracking voter sentiment, optimizing investment strategies, or monitoring brand perception. We offer products that are tailored for both beginners and advanced data professionals.